As a company listed on Nasdaq Copenhagen A/S, Genmab A/S is required to give a statement on how the company addresses the Recommendations for Corporate Governance issued by the Committee on Corporate Governance using the “comply-or-explain” principle. The current Recommendations for Corporate Governance were introduced in December 2020.
Below please find Genmab A/S’ Statutory Report on Corporate Governance according to the Danish Financial Statements Act, Section 107b (in Danish "Lovpligtig redegørelse for virksomhedsledelse, jf. årsregnskabslovens § 107 b").